Hycamtin, NSC 609699, Topotecan Hydrochloride

01

02

03

04 Looking for 119413-54-6 / Topotecan Hydrochloride API manufacturers, exporters & distributors?

PharmaCompass offers a list of Topotecan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Topotecan Hydrochloride manufacturer or Topotecan Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Topotecan Hydrochloride manufacturer or Topotecan Hydrochloride supplier.

PharmaCompass also assists you with knowing the Topotecan Hydrochloride API Price utilized in the formulation of products. Topotecan Hydrochloride API Price is not always fixed or binding as the Topotecan Hydrochloride Price is obtained through a variety of data sources. The Topotecan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Topotecan Hydrochloride

Synonyms

119413-54-6, Topotecan hcl, Hycamtin, Nogitecan hydrochloride, Topotecan (hydrochloride), Topotecan monohydrochloride

Cas Number

119413-54-6

Unique Ingredient Identifier (UNII)

956S425ZCY

About Topotecan Hydrochloride

An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.

Hycamtin, NSC 609699, Topotecan Hydrochloride Manufacturers

A Hycamtin, NSC 609699, Topotecan Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hycamtin, NSC 609699, Topotecan Hydrochloride, including repackagers and relabelers. The FDA regulates Hycamtin, NSC 609699, Topotecan Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hycamtin, NSC 609699, Topotecan Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Hycamtin, NSC 609699, Topotecan Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Hycamtin, NSC 609699, Topotecan Hydrochloride Suppliers

A Hycamtin, NSC 609699, Topotecan Hydrochloride supplier is an individual or a company that provides Hycamtin, NSC 609699, Topotecan Hydrochloride active pharmaceutical ingredient (API) or Hycamtin, NSC 609699, Topotecan Hydrochloride finished formulations upon request. The Hycamtin, NSC 609699, Topotecan Hydrochloride suppliers may include Hycamtin, NSC 609699, Topotecan Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Hycamtin, NSC 609699, Topotecan Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Hycamtin, NSC 609699, Topotecan Hydrochloride KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Hycamtin, NSC 609699, Topotecan Hydrochloride Drug Master File in Korea (Hycamtin, NSC 609699, Topotecan Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hycamtin, NSC 609699, Topotecan Hydrochloride. The MFDS reviews the Hycamtin, NSC 609699, Topotecan Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Hycamtin, NSC 609699, Topotecan Hydrochloride KDMF to evaluate the safety and efficacy of the drug.

After submitting a Hycamtin, NSC 609699, Topotecan Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hycamtin, NSC 609699, Topotecan Hydrochloride API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Hycamtin, NSC 609699, Topotecan Hydrochloride suppliers with KDMF on PharmaCompass.

Hycamtin, NSC 609699, Topotecan Hydrochloride Manufacturers | Traders | Suppliers

We have 2 companies offering Hycamtin, NSC 609699, Topotecan Hydrochloride

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers

6 USDMF

1 JDMF

4 KDMF

3 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers

22 FDA Orange Book

31 Europe

5 Canada

4 Australia

4 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

INJECTABLE;INJECTION - EQ 4MG BASE/VIAL

CAPSULE;ORAL - EQ 0.25MG BASE

CAPSULE;ORAL - EQ 1MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

6 DKSH

1 Faran Shimi Pharmaceutical

1 Gangwal Healthcare

1 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

1 Actylis

2 BASF

3 Gangwal Chemicals

1 Ingredion Pharma Solutions

6 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Pluviaendo

1 Qualicaps

5 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

11 Chewable & Orodispersible Aids

11 Taste Masking

10 Co-Processed Excipients

10 Direct Compression

8 Empty Capsules

7 Disintegrants & Superdisintegrants

6 Coating Systems & Additives

5 Thickeners and Stabilizers

5 Parenteral

4 Solubilizers

3 Granulation

2 Coloring Agents

2 Film Formers & Plasticizers

1 Topical

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

21 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions

20 Regulatory FDF Prices

MARKET PLACE

5 APIs

5 FDF Dossiers

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons